Biomedical Engineering Reference
In-Depth Information
length between normal and malignant cells from patients with chronic myeloid leukemia
measured by flow cytometry. Blood 95:1883-90.
Bruserud, O., Stapnes, C., Ersvaer, E., Gjertsen, B. T. and Ryningen, A. 2007. Histone
deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modula-
tion of gene expression in cancer cell. Curr Pharm Biotechnol 8:388-400.
Castor, A., Nilsson, L., Astrand-Grundstrom, I., Buitenhuis, M., Ramirez, C., Anderson, K.,
Strombeck, B., Garwicz, S., Bekassy, A. N., Schmiegelow, K., Lausen, B., Hokland, P.,
Lehmann, S., Juliusson, G., Johansson, B. and Jacobsen, S. E. 2005. Distinct patterns of
hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med 11:630-7.
Chen, Y. J., Sims-Mourtada, J., Izzo, J. and Chao, K. S. 2007. Targeting the hedgehog
pathway to mitigate treatment resistance. Cell Cycle 6:1826-30.
Christ, O., Lucke, K., Imren, S., Leung, K., Hamilton, M., Eaves, A., Smith, C. and Eaves, C.
2007. Improved purification of hematopoietic stem cells based on their elevated aldehyde
dehydrogenase activity. Haematologica 92:1165-72.
Cobaleda, C., Gutierrez-Cianca, N., Perez-Losada, J., Flores, T., Garcia-Sanz, R., Gonzalez, M.
and Sanchez-Garcia, I. 2000. A primitive hematopoietic cell is the target for the leukemic
transformation in human Philadelphia-positive acute lymphoblastic leukemia. Blood
95:1007-13.
Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van
Den Neste, E., Salles, G., Gaulard, P., Reyes, F., Lederlin, P. and Gisselbrecht, C. 2002.
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with
diffuse large-B-cell lymphoma. N Engl J Med 346:235-42.
Copland, M., Hamilton, A., Elrick, L. J., Baird, J. W., Allan, E. K., Jordanides, N., Barow, M.,
Mountford, J. C. and Holyoake, T. L. 2006. Dasatinib (BMS-354825) targets an earlier
progenitor population than imatinib in primary CML, but does not eliminate the quiescent
fraction. Blood 107:4532-9.
Copland, M., Pellicano, F., Richmond, L., Allan, E. K., Hamilton, A., Lee, F. Y., Weinmann, R.
and Holyoake, T. L. 2008. BMS-214662 potently induces apoptosis of chronic myeloid
leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors. Blood
111:2843-53.
Cortes, J., O'Brien, S. and Kantarjian, H. 2004. Discontinuation of imatinib therapy after
achieving a molecular response. Blood 104:2204-5.
Coulombel, L. 2004. Identification of hematopoietic stem/progenitor cells: strength and
drawbacks of functional assays. Oncogene 23:7210-22.
Coulombel, L., Eaves, A. C. and Eaves, C. J. 1983. Enzymatic treatment of long-term human
marrow cultures reveals the preferential location of primitive hemopoietic progenitors in
the adherent layer. Blood 62:291-7.
Cox, C. V., Evely, R. S., Oakhill, A., Pamphilon, D. H., Goulden, N. J. and Blair, A. 2004.
Characterization of acute lymphoblastic leukemia progenitor cells. Blood 104:2919-25.
Cozzio, A., Passegue, E., Ayton, P. M., Karsunky, H., Cleary, M. L. and Weissman, I. L.
2003. Similar MLL-associated leukemias arising from self-renewing stem cells and short-
lived myeloid progenitors. Genes Dev 17:3029-35.
Damle, R. N.,Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S. L., Buchbinder, A., Budman, D.,
Dittmar,K.,Kolitz,J.,Lichtman,S.M.,Schulman,P.,Vinciguerra,V.P.,Rai,K.R.,Ferrarini,
M. and Chiorazzi, N. 1999. Ig V gene mutation status and CD38 expression as novel prognostic
indicators in chronic lymphocytic leukemia. Blood 94:1840-7.
DeAngelo, D. J., Stone, R. M., Silverman, L. B., Stock, W., Attar, E. C., Fearen, I., Dallob, A.,
Matthews, C., Stone, J., Freedman, S. J. and Aster, J. 2006. A phase 1 clinical trial of the
notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma
(T-ALL) and other leukemias. J Clin Oncol 24:6585.
Dierks, C., Beigi, R., Stegert, M., Zirlik, K., Schmitt-Graeff, A., Veelken, H. andWarmuth, M.
2007. Expansion of BCR-ABL positive leukemic stem cells is dependent on Hedgehog
pathway activation. Blood 110:990a
